Table 4 Baseline status and clinical... | American Society of Hematology

Table 4

Baseline status and clinical course of patients achieving major cytogenetic response

Patient	Baseline hematologic/cytogenetic status	Disposition	No. of cycles received	Best cytogenetic response on study
001-009	CHR⁻/100% Ph⁺	Ongoing	14	CCyR
001-012	CHR⁺/95% Ph⁺	Ongoing	17	PCyR
005-001	CHR⁺/20% Ph⁺	Ongoing	32	CCyR
005-002	CHR⁺/45% Ph⁺	Ongoing	5	CCyR
009-002	CHR⁺/Not done	Ongoing	21	CCyR
010-001	CHR⁺/30% Ph⁺	Ongoing	16	CCyR
020-005	CHR⁺/90% Ph⁺	Ongoing	15	CCyR
021-004	CHR⁺/100% Ph⁺	Discontinued (to receive allograft)	3	PCyR
023-003	CHR⁺/74% Ph⁺	Discontinued (to receive cord blood transplant)	10	CCyR
028-001	CHR⁻/100% Ph⁺	Discontinued (failure to achieve meaningful response)	11	PCyR
028-002	CHR⁻/91% Ph⁺	Discontinued (failure to achieve meaningful response)	9	CCyR
071-002	CHR⁻/100% Ph⁺	Discontinued (disease progression)	10	PCyR
071-003	CHR⁻/40% Ph⁺	Discontinued (adverse event)	5	CCyR
090-002	CHR⁺/13% Ph⁺	Discontinued (withdrawal by request)	3	CCyR

Patient	Baseline hematologic/cytogenetic status	Disposition	No. of cycles received	Best cytogenetic response on study
001-009	CHR⁻/100% Ph⁺	Ongoing	14	CCyR
001-012	CHR⁺/95% Ph⁺	Ongoing	17	PCyR
005-001	CHR⁺/20% Ph⁺	Ongoing	32	CCyR
005-002	CHR⁺/45% Ph⁺	Ongoing	5	CCyR
009-002	CHR⁺/Not done	Ongoing	21	CCyR
010-001	CHR⁺/30% Ph⁺	Ongoing	16	CCyR
020-005	CHR⁺/90% Ph⁺	Ongoing	15	CCyR
021-004	CHR⁺/100% Ph⁺	Discontinued (to receive allograft)	3	PCyR
023-003	CHR⁺/74% Ph⁺	Discontinued (to receive cord blood transplant)	10	CCyR
028-001	CHR⁻/100% Ph⁺	Discontinued (failure to achieve meaningful response)	11	PCyR
028-002	CHR⁻/91% Ph⁺	Discontinued (failure to achieve meaningful response)	9	CCyR
071-002	CHR⁻/100% Ph⁺	Discontinued (disease progression)	10	PCyR
071-003	CHR⁻/40% Ph⁺	Discontinued (adverse event)	5	CCyR
090-002	CHR⁺/13% Ph⁺	Discontinued (withdrawal by request)	3	CCyR

CHR indicates complete hematologic response; CCyR, complete cytogenetic response; and PCyR, partial cytogenetic response.